NCT04987203 2025-08-22Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaAVEO Pharmaceuticals, Inc.Phase 3 Active not recruiting343 enrolled